← Leaderboards
Daniel F Hanley
Johns Hopkins University
$115,838,208
Attributed
$128,293,615
Total exposure
16
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $17.2M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$149,418,142 · 16
FDA$449,040 · 1
By mechanism
U24$65,208,134 · 5
U01$58,992,078 · 3
R01$25,467,550 · 4
R34$164,000 · 1
M01$35,420 · 4
Top collaborators
- Linda J Van Eldik5 shared
- Gayane Yenokyan5 shared
- Richard Thompson4 shared
- Jose A Luchsinger1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Janet T. Holbrook$51,624,279
- Robert A. Wise$33,179,807
- Mark Gregory Luciano$10,508,934
- Douglas A Jabs$24,554,490
- Richard Holubkov$11,946,832
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsInnovationSafetyEvaluationRandomizedProgramsLeadAlzheimer&AposEffectivenessPerformanceEnrollmentProtocols DocumentationSiteSpeedGrantDesignResourcesDoseMulticenter TrialsJointsCollaborationsScientistMulti-Site TrialStroke
Grant awards (62)
Metformin in Alzheimer's dementia Prevention (MAP)$6,451,136
R01 · FY2025 · AG
Johns Hopkins University Trial Innovation Center$4,887,750
U24 · FY2025 · TR · contact PI
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN$2,171,410
U24 · FY2025 · TR · contact PI
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation$1,462,441
U24 · FY2025 · HL · contact PI
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial$1,354,624
R01 · FY2025 · AG · contact PI
ASTRO: Adjuvant STeroid Outcomes in idiopathic subglottic stenosis: A randomized trial$921,009
U24 · FY2025 · HL · contact PI
Johns Hopkins University Trial Innovation Center$4,901,778
U24 · FY2024 · TR · contact PI
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial$2,140,865
R01 · FY2024 · AG · contact PI
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN$1,631,948
U24 · FY2024 · TR · contact PI
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation$1,450,909
U24 · FY2024 · HL · contact PI
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN$326,779
U24 · FY2024 · TR · contact PI
Johns Hopkins University Trial Innovation Center$4,972,809
U24 · FY2023 · TR · contact PI
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial$1,941,017
R01 · FY2023 · AG · contact PI
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN$1,812,738
U24 · FY2023 · TR · contact PI
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation$1,289,729
U24 · FY2023 · HL · contact PI
JHU Statistical and Safety Resource Center (SSRC)$853,971
U24 · FY2023 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$3,868,488
U24 · FY2022 · TR · contact PI
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial$1,966,656
R01 · FY2022 · AG · contact PI
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation$1,839,921
U24 · FY2022 · HL · contact PI
Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN$412,974
U24 · FY2022 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center HEAL Pain ERN Supplement$1
U24 · FY2022 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$2,869,346
U24 · FY2021 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$2,104,577
U24 · FY2021 · TR · contact PI
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial$2,078,174
R01 · FY2021 · AG · contact PI
Johns Hopkins-Tufts Trial Innovation Center$3,870,148
U24 · FY2020 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$1,614,467
U24 · FY2020 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$666,162
U24 · FY2020 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$3,870,970
U24 · FY2019 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$2,631,133
U24 · FY2019 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$3,871,734
U24 · FY2018 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$5,470,529
U24 · FY2017 · TR · contact PI
MISTIE III_ Lead Grant_ Cluster Application for the Clinical Coordinating Center$2,291,358
U01 · FY2017 · NS · contact PI
MISTIE III_ Lead Grant_ Cluster Application for the Clinical Coordinating Center$5,044,499
U01 · FY2016 · NS · contact PI
Johns Hopkins-Tufts Trial Innovation Center$3,893,602
U24 · FY2016 · TR · contact PI
Johns Hopkins-Tufts Trial Innovation Center$1,540,811
U24 · FY2016 · TR · contact PI
MISTIE III_ Lead Grant_ Cluster Application for the Clinical Coordinating Center$2,539,627
U01 · FY2015 · NS · contact PI
MISTIE III_ Lead Grant_ Cluster Application for the Clinical Coordinating Center$8,242,397
U01 · FY2014 · NS · contact PI
MISTIE III_ Lead Grant_ Cluster Application for the Clinical Coordinating Center$5,107,259
U01 · FY2013 · NS · contact PI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III)$2,452,564
U01 · FY2013 · NS · contact PI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III)$4,927,632
U01 · FY2012 · NS · contact PI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III)$5,506,211
U01 · FY2011 · NS · contact PI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III$5,506,211
U01 · FY2011 · NS · contact PI
ICH Removal: Minimally Invasive Surgery + rt-PA$1,623,497
R01 · FY2011 · NS · contact PI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III)$5,970,838
U01 · FY2010 · NS · contact PI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III$5,970,838
U01 · FY2010 · NS · contact PI
ICH Removal: Minimally Invasive Surgery + rt-PA$1,594,839
R01 · FY2010 · NS · contact PI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III)$2,716,322
U01 · FY2009 · NS · contact PI
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III$2,716,322
U01 · FY2009 · NS · contact PI
ICH Removal: Minimally Invasive Surgery + rt-PA$1,563,922
R01 · FY2009 · NS · contact PI
ICH Removal: Minimally Invasive Surgery + rt-PA$1,151,692
R01 · FY2008 · NS · contact PI
CLEAR IVH Phase III Planning Grant$164,000
R34 · FY2008 · NS · contact PI
INVESTIGATION OF DOSE/EFFICACY PROPERTIES OF INTRAVENTR*$75,000
R01 · FY2008 · FD · contact PI
ICH Removal: Minimally Invasive Surgery + rt-PA$677,353
R01 · FY2007 · NS · contact PI
EFFECT OF EXERCISE TRAINING AFTER STROKE$226
M01 · FY2007 · RR · contact PI
ICH Removal: Minimally Invasive Surgery + rt-PA$1,203,164
R01 · FY2006 · NS · contact PI
INVESTIGATION OF DOSE/EFFICACY PROPERTIES OF INTRAVENTR*$374,040
R01 · FY2006 · FD · contact PI
EFFECT OF EXERCISING TRAINING AFTER STROKE$6,439
M01 · FY2006 · RR · contact PI
ICH Removal: Minimally Invasive Surgery + rt-PA$1,271,571
R01 · FY2005 · NS
EFFECT OF EXERCISING TRAINING AFTER STROKE$17,944
M01 · FY2005 · RR
INVESTIGATION OF DOSE/EFFICACY PROPERTIES OF INTRAVENTR*$0
R01 · FY2005 · FD
Effect of exercising training after stroke$6,737
M01 · FY2004 · RR
Effect of Exercise Training on the Reorganization of the Sensorimotor System Aft$4,074
M01 · FY2004 · RR